New drug for treating melanoma and other cancers

post-image
Researchers at the University of Colorado Cancer Centre have published their work on NLRP3 - an intracellular complex found to participate in melanoma-mediated inflammation leading to tumour growth and progression. The researchers found that by inhibiting this complex, they can reduce inflammation and tumour growth. The studies have so far used an oral NLRP3 inhibitor (Dapansutrile) which has shown to be effective in treating gout and heart disease. It is currently being tested in COVID-19.  | https://medicalxpress.com/news/2021-04-drug-tumors.html?utm_source=nwletter&utm_medium=email&utm_campaign=daily-nwletter


What do you think?


You must be logged in to post a comment.
Comments

Related Posts

Healthcare

post-image

New pain relief though nerve cooling implant
26 July 2022 by Trevor Rowe 0 Comments

Healthcare

post-image

A defibrillator near every home
23 July 2022 by Lynn Wood 0 Comments

Healthcare

post-image

Phage therapy .. a new frontier in healthcare
26 June 2022 by Trevor Rowe 0 Comments